Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Aug 1;37(10):1625-1627.
doi: 10.1097/QAD.0000000000003624.

Antibody and T-cell responses elicited by coronavirus disease 2019 vaccination in people with HIV-1: the case of late presenters

Ali Ahmad  1 , Suzanne Samarani, Cecilia T Costiniuk
Affiliations
Comment

Antibody and T-cell responses elicited by coronavirus disease 2019 vaccination in people with HIV-1: the case of late presenters

Ali Ahmad et al. AIDS. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Comment on

References

    1. Augello M, Bono V, Rovito R, Tincati C, d’Arminio Monforte A, Marchetti G. Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection. AIDS 2023; 37:1503–1517. - PMC - PubMed
    1. Mullender C, da Costa KAS, Alrubayyi A, Pett SL, Peppa D. SARS-CoV-2 immunity and vaccine strategies in people with HIV. Oxford Open Immunol 2022; 3:iqac005. - PMC - PubMed
    1. Yau K, Chan CT, Abe KT, Jiang Y, Atiquzzaman M, Mullin SI, et al. Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis. CMAJ 2022; 194:E297–E305. - PMC - PubMed
    1. Oswald-Richter K, Grill SM, Leelawong M, Tseng M, Kalams SA, Hulgan T, et al. Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection. PLoS Pathog 2007; 3:e58. - PMC - PubMed
    1. Vergori A, Lepri AC, Cicalini S, Matusali G, Bordoni V, Lanini S, et al. HIV-VAC study group. Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV. Nat Commun 2022; 13:4922. - PMC - PubMed